Live Breaking News & Updates on Poster Discussions|Page 1

Stay updated with breaking news from Poster discussions. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

ImmVira presented latest encouraging clinical results of two proprietary products at ASCO 2023

/PRNewswire/ ImmVira submitted four abstracts covering latest results from Phase I/II clinical trials of MVR-T3011 IT (intratumoral injection) and MVR-T3011. ....

United States , American Society For Clinical Oncology Annual Meeting , Clinical Oncology Annual Meeting , Poster Discussions , Common Criteria , Adverse Events , Serious Adverse Event , Oncolytic Virus , Cancer Vaccine , Biosynthetic Exosome ,

Antengene To Present Latest Results from TORCH-2 Study of ATG-008 in Advanced Solid Tumors in Poster Discussion at ASCO 2023

/PRNewswire/ Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to. ....

South Korea , United States , Mccormick Place , Hong Kong , Peter Qian , Asia Pacific , Hong Kong Stock Exchange , Prnewswire Antengene Corporation Limited , Company Annual , Eastern Cooperative Oncology Group , Antengene Corporation Limited , American Society For Clinical Oncology Annual Meeting , Antengene Corporation , Mccormick Place Convention Center , Corporation Limited , Clinical Oncology Annual Meeting , Poster Discussions , Poster Discussion , Family Zhang , Chief Medical , Developmental Therapeutics , Discussion Session Date , Central Time , Beijing Time , Cervical Cancer Cohort , Nasopharyngeal Carcinoma ,